This is a preview of subscription content, log in via an institution to check access.
References
Benihoud, K., Lecerf, J. M., Bobe, P., and Kiger, N. Imbalance of MHC class I expression in 3LL tumour cells. Eur J Immunogen 18: 355, 1991
Biggar, R. J., Burnett, W., Mikl, J., and Nasca, P. Cancer among New York men at risk of acquired immunodeficiency syndrome. Internat J Cancer 43: 979–985, 1989
Bodmer, W. F., Browning, M. J., Krauss, P., Rowan, A., Bicknell, D. C., and Bodmer, J. G. Tumor escape from immune response by variation in HLA expression and other mechanisms. Ann NY Acad Sci 690: 42, 1993
Boshkov, L. K., Macen, J. L., and McFadden, G. Virus-induced loss of class I MHC antigens from the surface of cells infected with myxoma virus and malignant rabbit fibroma virus. J Immunol 148: 881, 1992
Cannon, M. J., Pisa, P., Fox, R. I., and Cooper, N. R. Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice. J Clin Invest 85: 1333, 1990
Chen, P. W. and Ananthaswamy, H. N. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2. J Immunol 151: 244, 1993
Conner, M. E. and Stern, P. L. Loss of MHC class I expression in cervical carcinomas. Int J Cancer 46: 1029, 1990
Cromme, F. V., Airey, J., Heemels, M.-T., Ploegh, H. L., Keating, P. J., Stern, P. L., Meijer, C. J. L. M., and Walboomers, J. M. M. Loss of transporter protein, encoded by the Tap-1 gene, is highly correlated with loss of HLA expression in cervical carcinoma. J Exp Med 179: 335–340, 1994
Elgin, S. DNase I hypersensitivity sites of chromatin. Cell 27: 413, 1981
Emslie-Smith, A. M., Arahata, K., and Engel, A. G. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Immunol 20: 224–231, 1989
Falk, K., Rötzschke, O., Stevanović, S., Jung, G., and Rammensee, H.-G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351: 290, 1991
Horibata, K. and Harris, A. W. Mouse myelomas and lymphomas in culture. Exp Cell Res 60: 61, 1970
Hui, K., Grosveld, F., and Festenstein, H. Rejection of transplantable AKR leukemia cells following MHC DNA-mediated cell transformation. Nature 311: 751, 1984
Johnson, N. A., Keeney, J., Hedayat, M., Wieties-Clary, K., Kranz, D. M., and Hansen, T. H. T Cell Receptor rearrangements in various S49 lymphoma sublines. Mol Immunol 29: 1325, 1992
Joncas, J. H., Russo, P., Brochu, P., Simard, P., Brisebois, J., Dube, J., Marton, D., Leclerc, J. M., Hume, H., and Rivard, G. E. Epstein-Barr virus polymophic B-cell lymphoma associated with leukemia and with congential immunodeficiencies. J Clin Oncol 8: 378–384, 1990
Joseph, L. J., Levy, E., Ozato, K., Hochman, J., and Shearer, G. M. Differential Lack of class 1 H-2d antigen expression by sublines of the BALB/c S49 T cell lymphoma. J Immunol 137: 4016–4020, 1986
Keeney, J. B., Hedayat, M., Myers, M., Connolly, J. M., and Hansen, T. H. Locus-specific regulation of Kd, Dd, and Ld class I genes in the BALB/c S49 lymphoma sublines. J Immunol 143: 2364, 1989a
Keeney, J. B. and Hansen, T. H. Cis-acting elements determine the locus-specific shutoff of class I major histocompatibility genes in murine S-49 lymphoma sublines. Proc Natl Acad Sci USA 86: 6288, 1989b
Kim, T. S. and Cohen, E. P. MHC antigen expression by melanomas recovered from mice treated with allogeneic mouse fibroblasts genetically modified for interleukin-2 secretion and the expression of melanoma-associated antigens. Cancer Immunol Immunother 38: 185, 1994
Koretz, K., Momburg, F., Otto, H. F., and Moller, P. Sequential induction of MHC antigens on autochthonous cells of the ileum affected by Crohn's disease. Amer J Path 129: 493, 1987
Leonhardt, H., Page, A. W., Weier, H., and Bestor, T. H. A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei. Cell 71: 865, 1992
Levitsky, H. I., Lazenby, A., Hayashi, R. J., and Pardoll, D. M. In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression. J Exp Med 170: 1215, 1994
Lurquin, C., van Pel, A., Mariame, B., de-Plaen, E., Szikora, J. P., Janssens, C., Reddehase, M. J., Lejeune, J., and Boon, J. Structure of the gene of tum−transplantation antigen P91A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells. Cell 58: 293, 1989
Maschek, U., Pulm, W., Segal, S., and Hammerling, G. J. Major histocompatibility complex class I genes in murine fibrosarcoma IC9 are down-regulated at the level of the chromain stucture. Mol Cell Biol 9(sn 7): 3136, 1989
Masucci, M. G. and Klein, E. Cell phenotype dependent expression of MHC class I antigens in Burkitt's lymphoma cell lines. Semin Cancer Biol 2: 63, 1991
Pelicci, P. G., Knowles II, D. M., Arlin, Z. A., Wieczorek, R., Luciw, P., Dina, D., Basilico, C., and Dalla-Favera, R. Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders: implications for lymphomagenesis. J Exp Med 164: 2049, 1986
Pfizenmaier, K., Scheurich, P., Schluter, C., and Kronke, M. Tumor necrosis factor enhances HLA-A, B, C and HLA-DR gene expression in human tumor cells. J Immunol 138: 975, 1987
Ralph, P., Hyman, R., Epstein, R., Nakoinz, I., and Cohn, M. Independence of θ and TL surface antigens and killing by thymidine, cortisol, phytohemagglutinin, and cyclic AMP in a murine lymphoma. Biochim Biophys Res Comm 55: 1085, 1973
Restifo, N. P., Esquivel, F., Kawakami, Y., Yewdell, J. W., Mule, J. J., Rosenberg, S. A., and Bennink, J. R. Identification of human cancers deficient in antigen processing. J Exp Med 177: 265, 1993
Rötzschke, O., Falk, K., Deres, K., Schild, H., Norda, M., Metzger, J., Jung, G., and Rammensee, H.-G. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic cells. Nature 348: 252, 1990
Sanderson, A. R. and Beverly, P. C. L. Interferon, β2-microglobulin, and immunoselection in the pathway to malignancy. Immunol Today 4: 211, 1983
Schendel, D. L., Gansbacher, B., Oberneder, R., Kriegmair, M., Hofstetter, A., Reithmuller, G., and Segurado, O. G. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. J Immunol 151: 4209, 1993
Spack, E. G., Lewis, E. D., Paradowski, B., Schinke, R. T., and Jones, P. P. Temporal order of DNA replication in the H-2 major histocompatibility complex of the mouse. Mol Cell Biol 12: 5174, 1992
Tanaka, K., Isselbacher, K. J., Khoury, G., and Jay, G. Reversal on oncogenesis by the expression of a major histocompatibility complex class I gene. Science 228: 26, 1985
Tanaka, K., Yoshioka, T., Bieberich, C., and Jay, G. Role of the major histocompatibility complex class I antigens in tumor growth and metastasis. Annu Rev Immunol 6: 359, 1988
Townsend, A., Rothbard, J., Gotch, Bahadur, G., Wraith, D., and McMichael, A. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44: 959, 1986
Van Bleek, G. and Nathenson, S. G. Isolation of an endogenously processed immunodominant viral peptide from the class I H-Kb molecule. Nature 348: 213, 1990
Van den Eynde, B., Lethe, B., van Pel, A., de Plaen, E., and Boon, T. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J Exp Med 173: 1373, 1991
Zeff, R. A., Zhao, Y.-F., Tatake, R., Lachman, H., Borriello, and S. G. Nathenson. Cis-and trans-repression of class I major histocompatibility gene expression in abelson virus-transformed murine leukemia. Blood 78: 524, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rubocki, R.J., Berrigan, B.E., Speaks, S.L. et al. Locus-specific de novo methylation down-regulates MHC class I in S49 lymphomas. Immunogenetics 43, 63–67 (1995). https://doi.org/10.1007/BF00186605
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00186605